Filtered By:
Source: Expert Review of Neurotherapeutics
Condition: Hemorrhagic Stroke
This page shows you your search results in order of relevance.
Order by Relevance | Date
Total 673 results found since Jan 2013.
Leukoaraiosis as an outcome predictor in the acute and subacute phases of stroke.
Authors: Fierini F, Poggesi A, Pantoni L
Abstract
INTRODUCTION: Leukoaraiosis (LA) is one of the neuroimaging features of cerebral small vessel disease and is associated with poor long-term prognosis. Areas covered: This narrative review focuses on the predictive role of LA on the evolution of the ischemic brain damage and on the clinical outcome in the subacute phase of stroke and in the short-term period afterwards. Expert commentary: In acute stroke, LA is associated with a less favorable fate of brain infarct and is a marker of increased risk of thrombolysis-related hemorrhagic transformation. The impaired cerebra...
Source: Expert Review of Neurotherapeutics - August 23, 2017 Category: Neurology Tags: Expert Rev Neurother Source Type: research
Select hyperacute complications of ischemic stroke: cerebral edema, hemorrhagic transformation, and orolingual angioedema secondary to intravenous altepase.
Authors: Bar B, Biller J
Abstract
INTRODUCTION: Remarkable advances have occurred in the management of acute ischemic stroke especially in regards to reperfusion treatments. With advances in reperfusion treatments come the risk of complications associated with these treatments. Areas covered: The paper focuses on three acute complications that can occur in the setting of acute ischemic stroke: cerebral edema, hemorrhagic transformation, and orolingual angioedema following administration of alteplase, a recombinant tissue plasminogen activator. Predictors of the development of these complications are reviewed. The mana...
Source: Expert Review of Neurotherapeutics - September 15, 2018 Category: Neurology Tags: Expert Rev Neurother Source Type: research
Effect of antiplatelet pretreatment on safety and efficacy outcomes in acute ischemic stroke patients after intravenous thrombolysis: a systematic review and meta-analysis.
CONCLUSION: There was no significant difference in sICH and mortality between patients with and without antiplatelet pretreatment. Besides, antiplatelet pretreatment did not adversely affect the efficacy outcomes. The prevalence of sICH among Asians receiving antiplatelet pretreatment was relatively high. Additionally, it needs to be noticed that the effect of preexisting antiplatelet on clinical outcomes may be dependent on post thrombolytic antiplatelet regiments.
PMID: 30807235 [PubMed - as supplied by publisher]
Source: Expert Review of Neurotherapeutics - February 27, 2019 Category: Neurology Tags: Expert Rev Neurother Source Type: research
Movement disorders and cerebrovascular diseases: from pathophysiology to treatment.
Authors: Caproni S, Colosimo C
Abstract
INTRODUCTION: Cerebrovascular diseases are one of the most common causes of secondary movement disorders. Hypokinetic or hyperkinetic movement disorders may occur after an ischemic or hemorrhagic stroke, either immediately or thereafter. Such disorders are also known to be caused by diffuse leukoaraiosis, vascular malformations and dural fistulas in the basal ganglia or other brain regions. Area covered: The aim of this review was to describe movement disorders secondary to cerebrovascular diseases, and highlight their pivotal pathophysiological aspects, clinical features, diagn...
Source: Expert Review of Neurotherapeutics - December 17, 2016 Category: Neurology Tags: Expert Rev Neurother Source Type: research
Intracerebral hemorrhage: an update on diagnosis and treatment.
We describe the causes, diagnosis (including new brain imaging biomarkers), classification, pathophysiological understanding, treatment (medical and surgical), and secondary prevention of ICH. Expert opinion: In recent years, significant advances have been made in deciphering causes, understanding pathophysiology, and improving acute treatment and prevention of ICH. However, the clinical outcome remains poor and many challenges remain. Acute interventions delivered rapidly (including medical therapies - targeting hematoma expansion, hemoglobin toxicity, inflammation, edema, anticoagulant reversal - and minimally invasive s...
Source: Expert Review of Neurotherapeutics - June 13, 2019 Category: Neurology Tags: Expert Rev Neurother Source Type: research
Risk factors for intracranial hemorrhage after mechanical thrombectomy: A systematic review and meta-analysis.
Conclusion: Many predictors of ICH were identified, however, given the lack of robust evidence, larger cohort studies should be prioritized to confirm these predictors.
PMID: 31200607 [PubMed - as supplied by publisher]
Source: Expert Review of Neurotherapeutics - June 16, 2019 Category: Neurology Tags: Expert Rev Neurother Source Type: research
Developments in distinguishing secondary vascular headache from Primary headache disorders in clinical practice
Expert Rev Neurother. 2021 Sep 23. doi: 10.1080/14737175.2021.1984882. Online ahead of print.ABSTRACTIntroductionVascular headaches are secondary headache disorders with potentially devastating consequences if missed. Clinicians often struggle to distinguish these from primary headache disorders whereby there is no underlying structural pathology. Here the authors describe the advancement in our understanding of vascular headache disorders, their clinical presentation and the developments in neuroimaging that facilitate diagnosis.Areas coveredHere the authors discuss the definition of primary and secondary headache disorde...
Source: Expert Review of Neurotherapeutics - September 23, 2021 Category: Neurology Authors: Sophie Dorsey Fayyaz Ahmed Source Type: research
